Results 111 to 120 of about 25,306 (274)

The clinical spectrum of sporadic and familial forms of frontotemporal dementia [PDF]

, 2016
The term frontotemporal dementia (FTD) describes a clinically, genetically and pathologically diverse group of neurodegenerative disorders. Symptoms of FTD can present in individuals in their twenties through to their nineties, but the mean age at onset ...
Rohrer, JD, Woollacott, IO
core   +1 more source

Comparative Analysis of the Incidence, Prevalence, and Survival of 8 Types of Parkinsonism in a Population‐Based Study with 367 Million Person Years of Observation over 21 Years

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Findings are contradictory regarding changes in the incidence and prevalence of Parkinson's disease (PD) over time; data for other parkinsonian disorders are rare. Objectives To analyze temporal trends in the incidence and prevalence of eight parkinsonisms (PD, MSA, PSP, CBS, DLB, vascular parkinsonism, drug‐induced parkinsonism ...
Sacha E. Gandhi, Katherine A. Grosset, Prasanth A. Iruthayaraj, Romel Gravesande, Lance Lee, Cathal Doyle, Yoav Ben‐Shlomo, Donald G. Grosset   +7 more
wiley   +1 more source

Quality of life in patients with progressive supranuclear palsy: a review of literature and implications for practice

Frontiers in Neurology
Progressive supranuclear palsy (PSP) is an atypical form of parkinsonism characterized by tauopathy, manifesting as oculomotor dysfunction, postural instability, akinesia, and cognitive/language impairments.
Michał Markiewicz, Natalia Madetko-Alster, Piotr Alster   +2 more
doaj   +1 more source

A Short Version of Carers' Quality of Life Questionnaire for Parkinsonism: Data from Progressive Supranuclear Palsy Network

Movement Disorders Clinical Practice, EarlyView.
Abstract Background and objectives Caregivers of progressive supranuclear palsy (PSP) patients frequently show significant distress. The Parkinsonism Carers quality of life (QoL) (PQoL Carer) is a valid tool evaluating the effect of PSP on caregivers' QoL.
Arianna Cappiello, Giovanna Calandra‐Buonaura, Roberto Ceravolo, Saverio Coralli, Sofia Cuoco, Eleonora del Prete, Francesca di Biasio, Daniela Frosini, Vittorio Gualtieri, Davide Mascioli, Luisa Sambati, Tommaso Schirinzi, Alessandro Stefani, Elisa Umbertini, Marco Aiello, Matteo Costanzo, Rosa de Micco, Giovanni Fabbrini, Gaetano Failla, Chiara Longo, Maria Chiara Malaguti, Nicola Modugno, Enrica Olivola, Noemi Maria Carola Russo, Alessandro Tessitore, Andrea Ciammola, Carlo Colosimo, Anna de Rosa, Laura de Togni, Alessio di Fonzo, Vincenzo Moschella, Andrea Pilotto, Francesca Spagnolo, Roberta Zangaglia, Paolo Barone, Marina Picillo, the PSP‐NET study group, Maria Autuori, Anna Rosa Avallone, Ilaria Cani, Giannicola Carozzo, Nicola Grotteschi, Maria Mancini, Clara Simonetta, Maria Francesca Tepedino, Henri Zenuni, Simone Aloisio, Ruggero Bacchin, Lorena Belli, Daniele Belvisi, Francesco Marchet, Sara Pietracupa, Sara Satolli, Maria Concetta Altavista, Marta Filidei, Giulia Lazzeri, Simone Malaspina, Alessando Padovani, Gabriele Riccio, Andrea Mirko Tedesco, Susanne Buechner, Laura Bonanni, Marianna Capecci, Maria Gabriella Ceravolo, Massimo Cincotta, Maria Francesca de Pandis, Raffaella di Giacopo, Lorenza Leonardi, Leonardo Lopiano, Fabrizio Stocchi, Laura Vacca, Sara Varanese, Maristella Piccininni, Maurizio Zibetti   +73 more
wiley   +1 more source

Annona muricata (graviola): toxic or therapeutic [PDF]

, 2008
This paper examines annona muricata (graviola): toxic or ...
Gray, A.I., Hollinshead, J., Jones, L., Jones, P.W., Mohanty, S., Thomas, D., Watson, A.A., Watson, D.G.   +7 more
core  

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid. [PDF]

, 2016
BackgroundClinical diagnosis of parkinsonian syndromes like Parkinson's disease (PD), corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) is hampered by overlapping symptomatology and lack of diagnostic biomarkers, and definitive ...
Boman, Andrea, Boxer, Adam, Karydas, Anna, Kågedal, Katarina, Miller, Bruce, Rojas, Julio C, Seeley, William W, Svenningsson, Per, Svensson, Samuel   +8 more
core   +1 more source

Endemic atypical parkinsonism [PDF]

Journal of the Neurological Sciences, 2018
Silveira-Moriyama, L, Lees, AJ
openaire   +3 more sources

Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Clinical outcome assessments (COAs) are essential for evaluating symptom severity, treatment response, and disease progression in Parkinson's disease (PD). As clinical knowledge evolves, it is necessary to revisit the recommendation status on the COAs to ensure their continued relevance and validity. Objectives To provide an updated
Evita Papathoma, Panagiota Tsitsi, Nirosen Vijiaratnam, Camila Aquino, Stephen R. Duma, Norbert Kovacs, Kigocha Lameck Okeng'o, Aparna Wagle Shukla, Roongroj Bhidayasiri, Tiago A. Mestre, Alvaro Sanchez Ferro, Alberto J. Espay, Michelle H.S. Tosin, Matej Skorvanek, Ioanna Markaki   +14 more
wiley   +1 more source

Late Onset Neurodegeneration with Brain-Iron Accumulation Presenting as Parkinsonism

Case Reports in Neurological Medicine, 2012
Neurodegeneration with brain-iron accumulation (NBIA) encompasses a family of neurodegenerative disorders connected by evidence of abnormal brain iron deposition.
Robert Fekete
doaj   +1 more source

Correlating familial Alzheimer’s disease gene mutations with clinical phenotype [PDF]

, 2010
Alzheimer’s disease (AD) causes devastating cognitive impairment and an intense research effort is currently devoted to developing improved treatments for it.
Rossor, M.N., Ryan, N.S.
core   +1 more source